We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Followup of Infants Fed Non-routine Infant Formula

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00665938
Recruitment Status : Completed
First Posted : April 24, 2008
Last Update Posted : January 31, 2012
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to compare physical development of infants fed one of three study formulas.

Condition or disease Intervention/treatment
Healthy Other: Infant formula

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 183 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Study Start Date : October 2006
Primary Completion Date : December 2011
Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Active Comparator: 1 Other: Infant formula

Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)

Arm 2. partially hydrolyzed infant formula with probiotics

Arm 3. extensively hydrolyzed infant formula with probiotics

Other Name: No other names are applicable to the 3 intervention arms
Experimental: 2 Other: Infant formula

Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)

Arm 2. partially hydrolyzed infant formula with probiotics

Arm 3. extensively hydrolyzed infant formula with probiotics

Other Name: No other names are applicable to the 3 intervention arms
Experimental: 3 Other: Infant formula

Arm 1. extensively hydrolyzed infant formula without probiotics (Nutramigen LIPIL)

Arm 2. partially hydrolyzed infant formula with probiotics

Arm 3. extensively hydrolyzed infant formula with probiotics

Other Name: No other names are applicable to the 3 intervention arms


Outcome Measures

Primary Outcome Measures :
  1. Achieved weight [ Time Frame: 5 years ]

Secondary Outcome Measures :
  1. Tolerance [ Time Frame: 1 year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Months to 4 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Completed Study 3369-5

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00665938


Sponsors and Collaborators
Mead Johnson Nutrition
Investigators
Study Director: Deolinda Scalabrin, MD Mead Johnson Nutrition
More Information

Responsible Party: Kim Merkel, Mead Johnson
ClinicalTrials.gov Identifier: NCT00665938     History of Changes
Other Study ID Numbers: 3369-6
First Posted: April 24, 2008    Key Record Dates
Last Update Posted: January 31, 2012
Last Verified: January 2012

Keywords provided by Mead Johnson Nutrition:
Physical development